Literature DB >> 24728305

ADAM33 gene polymorphisms are associated with the risk of idiopathic pulmonary fibrosis.

Soo-Taek Uh1, An-Soo Jang, Sung-Woo Park, Jong-Sook Park, Chang-Gi Min, Yong Hoon Kim, Byung-Lae Park, Hyoung Doo Shin, Dong Soon Kim, Choon-Sik Park.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea and worsening lung function due to remodeling of the lung, including epithelial mesenchymal transition. ADAM33 is a disintegrin and metalloprotease domain-containing protein, which may be related to lung fibrosis by exerting angiogenesis and remodeling of the lung. Thus, we evaluated the association of single-nucleotide polymorphisms (SNPs) of ADAM33 with the risk of IPF.
METHODS: A total of 237 patients with IPF and 183 healthy subjects participated in the present study. Nine polymorphisms were selected. Genotyping was performed by single-base extension. Polymorphisms and haplotypes were analyzed for associations with the risk of IPF using multiple logistic regression models controlling for age, gender, and smoking status as covariates.
RESULTS: All SNPs were in Hardy-Weinberg equilibrium. The minor allele frequency (MAF) of rs628977G>A in intron 21 was significantly lower in subjects with surgical IPF than in normal controls in the recessive model [33.2 vs. 38.0 %, p = 0.02, OR = 0.40 (0.19-0.84)]. When the subjects with clinical IPF were included, the difference in MAF persisted with a p value of 0.03 [OR = 0.50 (0.27-0.94)].
CONCLUSIONS: ADAM33 rs628977G>A was marginally associated with a decreased risk of IPF in a recessive model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728305     DOI: 10.1007/s00408-014-9578-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  40 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma.

Authors:  H Jongepier; H M Boezen; A Dijkstra; T D Howard; J M Vonk; G H Koppelman; S L Zheng; D A Meyers; E R Bleecker; D S Postma
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

3.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

Review 4.  ADAMs: focus on the protease domain.

Authors:  R A Black; J M White
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

Review 5.  Lung inflammation and fibrosis.

Authors:  P A Ward; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 6.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

7.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

Review 8.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

9.  Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice.

Authors:  I Gur; R Or; M J Segel; M Shriki; G Izbicki; R Breuer
Journal:  Exp Lung Res       Date:  2000 Oct-Nov       Impact factor: 2.459

10.  The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation.

Authors:  Zhijun Jie; Meiling Jin; Yingyun Cai; Chunxue Bai; Yao Shen; Zhenghong Yuan; Yunwen Hu; Stephen Holgate
Journal:  Respir Physiol Neurobiol       Date:  2009-07-25       Impact factor: 1.931

View more
  2 in total

1.  ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population.

Authors:  Bo Shen; Rong Lin; Cai-Chun Wang; Jing Rei; Yan Sun; Yong-Le Yang; Ying-Ying Lin
Journal:  Biomed Rep       Date:  2017-02-08

2.  Genetic association of ADAM33 polymorphisms with childhood asthma in Chinese Han population: A case-control study.

Authors:  Xuecong Ning; Yunxia Zhang; Hongzhi Wu; Linlin Bai; Cuike Gong; Zhihua Wang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.